Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial - Huang, Yi‐Wen; Qin, Albert; Fang, Jane; Wang, Ting‐Fang; Tsai, Chung‐Wei; Lin, Ko‐Chung; Teng, Ching‐Leou; Larouche, Richard (British journal of clinical pharmacology, 2022)
Keywords: Antiviral Agents - adverse effects; first‐in‐human; Humans; interferon; Interferon alpha-2 - adverse effects; Interferon-alpha - adverse effects; pegylated interferon; phase 1; Polyethylene Glycols - adverse effects; Recombinant Proteins - adverse effects; phase 1; pegylated interferon; first-in-human; interferon